FFA
TVTX icon

Farther Finance Advisors’s Travere Therapeutics TVTX Stock Holding History

Farther Finance Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Sell
301
-36
-11% -$1.6K ﹤0.01% 4090
2026
Q1 		$10.6K Sell
337
-157
-32% -$4.69K ﹤0.01% 4074
2025
Q4 		$18.9K Buy
494
+380
+333% +$12.4K ﹤0.01% 3493
2025
Q3 		$2.73K Buy
114
+103
+936% +$1.94K ﹤0.01% 4017
2025
Q2 		$163 Hold
11
– – ﹤0.01% 4236
2025
Q1 		$192 Hold
11
– – ﹤0.01% 3956
2024
Q4 		$192 Hold
11
– – ﹤0.01% 3666
2024
Q3 		$154 Hold
11
– – ﹤0.01% 3705
2024
Q2 		$91 Sell
11
-134
-92% -$902 ﹤0.01% 3611
2024
Q1 		$1.06K Hold
145
– – ﹤0.01% 2747
2023
Q4 		$1.3K Buy
+145
New +$1.06K ﹤0.01% 2623

Other funds holding TVTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Farther Finance Advisors's TVTX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Travere Therapeutics (TVTX) stake by 11% in Q2 2026, selling an estimated $1.6K and leaving 301 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4090.

Farther Finance Advisors first reported a position in TVTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.9K in Q4 2025. 110 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Farther Finance Advisors held 301 shares of Travere Therapeutics worth $17.2K as of Q2 2026.
  • Farther Finance Advisors sold 36 Travere Therapeutics shares in Q2 2026, an estimated $1.6K.
  • Travere Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4090 holding.
  • Farther Finance Advisors first reported a position in Travere Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Travere Therapeutics position peaked at $18.9K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.